SHANTHA WEST INC has a total of 18 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are IMMUNAS PHARMA INC, 4TEEN4 Pharmaceuticals GmbH and SHANGHAI YILE BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 3 | |
#3 | Canada | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Glassy Mark C | 13 |
#2 | Chakrabarti Subhra | 12 |
#3 | Mukerjee Sonjoy | 12 |
#4 | Mcknight Michael E | 6 |
#5 | Glassy Mark | 4 |
#6 | Mcknight Mike | 3 |
#7 | Mckinght Michael E | 1 |
Publication | Filing date | Title |
---|---|---|
WO2007127160A2 | Agrm2 antigen | |
CA2559172A1 | Therapeutic use of rm1 antigen | |
US7238353B2 | Antibodies that recognize hyperproliferative cells and methods of making and using same |